Methylation of Aurora kinase A by MMSET reduces p53 stability and regulates cell proliferation and apoptosis
- Authors
- Park, Jin Woo; Chae, Yun-Cheol; Kim, Ji-Young; Oh, Hyein; Seo, Sang-Beom
- Issue Date
- Nov-2018
- Publisher
- NATURE PUBLISHING GROUP
- Citation
- ONCOGENE, v.37, no.48, pp 6212 - 6224
- Pages
- 13
- Journal Title
- ONCOGENE
- Volume
- 37
- Number
- 48
- Start Page
- 6212
- End Page
- 6224
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/556
- DOI
- 10.1038/s41388-018-0393-y
- ISSN
- 0950-9232
1476-5594
- Abstract
- The histone methyltransferase multiple myeloma SET domain protein (MMSET/WHSC1) is highly expressed in diverse tumor types, and its expression appears to be involved in cell proliferation. In this study, we report that MMSET interacts with and methylates Aurora kinase A (AURKA). We show that MMSET-mediated methylation of AURKA induces interaction with p53 as well as enhanced kinase activity of AURKA, which results in the proteasomal degradation of p53. MMSET-mediated p53 degradation increases cell proliferation and results in oncogenic activity. Furthermore, knockdown of MMSET potently inhibits tumorigenic cells and renders them sensitive to growth inhibition by the therapeutic drug, alisertib (AURKA inhibitor). Taken together, our results suggest that MMSET is a regulator of p53 stability via methylation of AURKA in proliferating cells and might be a potential therapeutic target in solid tumors.
- Files in This Item
-
- Appears in
Collections - College of Natural Sciences > Department of Life Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.